Short-term adverse events after COVAXIN vaccination in adolescents (15–18 Years) in Northern India: Frequency, predictors, and reporting behavior
Background: India initiated COVID-19 vaccination for adolescents (aged 15–18 years) on January 3, 2022, exclusively using COVAXIN. Adolescent-specific safety data remain limited, and adverse event following immunization (AEFI) reporting is notably low. This study evaluated the frequency, characteris...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Article |
| שפה: | אנגלית |
| יצא לאור: |
Elsevier
2025-07-01
|
| סדרה: | Clinical Epidemiology and Global Health |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S221339842500171X |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|